Search research articles
Contact Us
Filters
Showing results (281-290 of 306) with videos related to
Page
of 31
Sort By:
Plos One
|
December 24, 2019
Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study
Veronica Bordoni, Bruno Brando, Pierluca Piselli, et al.
Frontiers in Pharmacology
|
July 5, 2021
Lactoferrin Against SARS-CoV-2: <i>In Vitro</i> and <i>In Silico</i> Evidences
Elena Campione, Caterina Lanna, Terenzio Cosio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 26, 2021
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C
Velia Chiara Di Maio, Silvia Barbaliscia, Elisabetta Teti, et al.
Sexually Transmitted Infections
|
May 12, 2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy
Lavinia Fabeni, Claudia Alteri, Giulia Berno, et al.
Journal of Global Antimicrobial Resistance
|
August 18, 2016
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro
Claudia Alteri, Matteo Surdo, Velia Chiara Di Maio, et al.
Plos One
|
February 21, 2018
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients
Lucia Taramasso, Antonio Di Biagio, Francesca Bovis, et al.
International Journal of Environmental Research and Public Health
|
October 23, 2021
Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence
Elena Campione, Caterina Lanna, Terenzio Cosio, et al.
The New Microbiologica
|
November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project
Massimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
Scientific Reports
|
April 7, 2022
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020
Alessia Lai, Annalisa Bergna, Stefano Toppo, et al.
Expert Review of Anti-Infective Therapy
|
December 25, 2018
Real life experiences in HCV management in 2018
Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 306) with videos related to
Sort By:
Page
of 31
Plos One
|
December 24, 2019
Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study
Veronica Bordoni, Bruno Brando, Pierluca Piselli, et al.
Frontiers in Pharmacology
|
July 5, 2021
Lactoferrin Against SARS-CoV-2: <i>In Vitro</i> and <i>In Silico</i> Evidences
Elena Campione, Caterina Lanna, Terenzio Cosio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 26, 2021
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C
Velia Chiara Di Maio, Silvia Barbaliscia, Elisabetta Teti, et al.
Sexually Transmitted Infections
|
May 12, 2019
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy
Lavinia Fabeni, Claudia Alteri, Giulia Berno, et al.
Journal of Global Antimicrobial Resistance
|
August 18, 2016
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro
Claudia Alteri, Matteo Surdo, Velia Chiara Di Maio, et al.
Plos One
|
February 21, 2018
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients
Lucia Taramasso, Antonio Di Biagio, Francesca Bovis, et al.
International Journal of Environmental Research and Public Health
|
October 23, 2021
Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence
Elena Campione, Caterina Lanna, Terenzio Cosio, et al.
The New Microbiologica
|
November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project
Massimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
Scientific Reports
|
April 7, 2022
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020
Alessia Lai, Annalisa Bergna, Stefano Toppo, et al.
Expert Review of Anti-Infective Therapy
|
December 25, 2018
Real life experiences in HCV management in 2018
Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, et al.
Page
of 31